Oxid Med Cell Longev (2019) 2019:9613090
Del codice della Carta di Credito non rimane traccia in nessuno dei nostri archivi
Nearly five in every 1,000 users of semaglutide drugs developed pancreatitis, compared to one of every 1,000 users of bupropion-naltrexone, the active ingredients in the weight-loss drug Contrave, according to a report in the JAMA medical journal
We are hopeful about the potential to bring a first-of-its-kind treatment option to people living with moderate-to-severe OSA and obesity, who currently have no pharmaceutical treatments for the underlying disease, says a spokesperson for Eli Lilly
Doeppner TR, Kaltwasser B, Elali A, Zechariah A, Hermann DM, Bhr M
Acknowledgment The authors gratefully acknowledge the Scientific Publishing Department, Health Research Center, Ministry of Defense Health Services, Riyadh, Saudi Arabia, for the English language editing